Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
A phase 2 trial of Iopofosine I 131 single dose in waldenström macroglobulinaemia, multiple myeloma, chronic lymphocytic leukaemia, non-Hodgkin lymphoma, mantle cell lymphoma and diffuse large B-cell lymphoma, run by Cellectar Biosciences, Inc., active and no longer recruiting.
Overview
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom is a phase 2 interventional study registered as NCT02952508 by Cellectar Biosciences, Inc., with 120 participants enrolled, started 2017-07-26 and due to reach its primary completion in 2026-06-22. Interventions recorded: Iopofosine I 131 single dose, Iopofosine I 131 multiple dose and Iopofosine I 131 fractionated dose.
Similar pages
not linked directly; found by shared links- TrialA Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Shares Non-Hodgkin lymphoma (all types), Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma, Multiple myeloma and the tag pipeline.
- TrialGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma and the tag pipeline.
- TrialDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Shares Waldenström macroglobulinaemia, Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialStudy of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialSARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
Shares Non-Hodgkin lymphoma (all types), Multiple myeloma and the tag pipeline.
- TreatmentCTX112
Shares Mantle cell lymphoma, Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma and the tag pipeline.
- TrialT-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialSepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.